FASN and cancer: For example, statins (inhibitors of cholesterol synthesis) are currently tested in multiple clinical trials as anti-cancer agents [115], and TVB-2640, an inhibitor of FASN, is currently evaluated in six clinical trials either as a single agent or in combination with others [116].